Hostname: page-component-848d4c4894-4rdrl Total loading time: 0 Render date: 2024-06-16T19:49:17.398Z Has data issue: false hasContentIssue false

Remarks by Frederick M. Abbott

Published online by Cambridge University Press:  28 February 2017

Frederick M. Abbott*
Affiliation:
Edward Ball Eminent Scholar of International Law, Florida State University College of Law

Abstract

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Intellectual Property Rights in Global Trade Framework: IP Trends in Developing Countries
Copyright
Copyright © American Society of International Law 2004

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

3 See <http://www.iprsonline.org> (Cambridge University Press, forthcoming).

4 See Abbott, Frederick M., The Doha Declaration on the TRIPS Agreement and Public Health: Lighting a Dark Corner at the WTO, 5 J. Int’l Econ. L. 469 (2002)CrossRefGoogle Scholar.

5 Paragraph 7 of the Doha Declaration is implemented by decisions of the WTO TRIPS Council and General Council; see Decision of the Council for TRIPS of 27 June 2002 (JP/C/25, July 1, 2002) and Decision of the General Council of 8 July 2002 (WT/L/478, July 12, 2002).

6 I have prepared a detailed analysis of these negotiations under the working title “The Containment of TRIPS to Promote Public Health,” which will be published in due course.

7 The draft text of the U.S.—Morocco Free Trade Agreement was posted by USTR the day after this panel met (USTR Releases Draft Texts of U.S.-Morocco FTA, April 2, 2004, available at <http://www.ustr.gov>).

8 See U.S. Federal Trade Commission, Generic Drug Entry Prior to Patent Expiration: An FTC Study, July 2002, available at <http://www.ftc.gov/os/2002/07/genericdrugstudy.pdf>.